Page 16 - Pharma Companies

The supply side

Ramping up vaccine availability has become critical

Dr Reddy's to also use govt cold chain infra for Sputnik V distribution

The vaccine would be transported in frozen form by air and road

Dr Reddy's to submit more data on Covid-19 vaccine Sputnik V by July

Colour-coded doses will have two different antigens

The second wave: Pharma stocks make a comeback as Covid-19 cases rise

However, analysts say these stocks may not deliver bumper returns like last year

Covid-19 vaccine: Real-world data to decide commercial marketing approval

Two such vaccines are Covishield, made by the Serum Institute of India (SII), and Covaxin by Bharat Biotech

J&J in talks with Centre for trial of single-shot Covid-19 vaccine

Russia's Sputnik V is another contender to get approval from the Indian drug regulator

Govt asks drug makers to ramp up remdesivir production to full capacity

The government on Wednesday said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity by next week.

Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil

Biotechnology major Biocon on Monday said its subsidiary has joined hands with Libbs Farmaceutica to launch generic drugs in Brazil, the world's sixth most populous country.

Status check of PLI schemes that aim to make India world's factory

Last year, the govt introduced a PLI scheme for mobile phones, electronic components, critical pharma drugs and medical devices, which saw huge traction among global as well as Indian manufacturers

Natco Pharma's board approves acquiring 1% in its Canadian subsidiary

Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary

Will supply more doses of AstraZeneca vaccine to UK later, says Serum

Senior officials in New Delhi confirmed that there was no ban on exports from India, and no plans to do so either.

PE/VC investments gather pace in February: Here're the top 5 deals

The top 10 investments accounted for 69 per cent of the total deal value, according to Aurum Equity Partners

India emerges global manufacturing hub for Covid-19 vaccine Sputnik V

Gland Pharma to make 252 mn doses, Hetero 100 mn doses, Strides may also join the fray

Four IPOs get investors' backing; chemical firm and jeweler make their mark

Anupam Rasayan's Rs 760-crore offer was subscribed 45 times; Kalyan Jewellers' IPO was subscribed 60 per cent on the first day of the issue

Price talks on Russia's Sputnik V Covid-19 vaccine yet to kick off

Rs 150/dose not ceiling price; cost to be fixed individually

Activists, drug groups split over suspending Covid-19 shot patents

Some 100 nations have expressed support, as has Doctors Without Borders (MSF) and World Health Organization head Tedros Adhanom Ghebreyesus.

Parikh family, former promoters of Zandu, exits pharma business

Sells stake in drug firm ZCL to PE firm Advent for Rs 1,600 cr

Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand

Cipla stock went up by almost 3 per cent on Tuesday

Cipla receives USFDA nod for nasal spray for treating migraine attacks

Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) for Sumatriptan Nasal Spray, indicated for the treatment of migraine attacks

Russian, Chinese hacking groups target pharma companies for Covid-19 data

Singapore-based cyber intelligent firm Cyfirma says 15 active hacking campaigns are underway; US, UK and Japan among a slew of other nations also on cybercriminals' target list